- Home
- CUVL vs FENC Comparison
CUVL vs FENC Comparison
Compare CUVL & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$6.90
HOLD
Current Price
$11.85
Company Overview
Basic Information| Metric | CUVL | FENC |
|---|---|---|
| Founded | N/A | 1996 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.9M | 411.0M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | CUVL | FENC |
|---|---|---|
| Price | $6.90 | $11.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 3.3K | ★ 167.8K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | ★ N/A | $197.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.20 | $5.65 |
| 52 Week High | $7.89 | $13.25 |
Technical Indicators
Market Signals| Indicator | CUVL | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 60.19 |
| Support Level | $6.60 | $9.74 |
| Resistance Level | $7.04 | N/A |
| Average True Range (ATR) | 0.27 | 0.72 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 76.70 | 66.79 |
Price Performance
Historical Comparison CUVL
FENC
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.